Intuitive Surgical (NASDAQ:ISRG) Issues Earnings Results

Intuitive Surgical (NASDAQ:ISRG) issued its quarterly earnings data on Thursday. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.40 by $0.10, Briefing.com reports. The business had revenue of $1.89 billion for the quarter, compared to the consensus estimate of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 13.27%. The company’s quarterly revenue was up 11.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.00 EPS.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $366.34 on Friday. Intuitive Surgical has a one year low of $254.85 and a one year high of $403.76. The stock has a 50-day moving average of $386.84 and a 200 day moving average of $343.10. The company has a market capitalization of $129.85 billion, a price-to-earnings ratio of 66.13, a PEG ratio of 5.78 and a beta of 1.36.

Analysts Set New Price Targets

A number of research firms have recently weighed in on ISRG. Robert W. Baird reduced their target price on shares of Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a research report on Friday. Piper Sandler upped their target price on shares of Intuitive Surgical from $425.00 to $435.00 and gave the stock an “overweight” rating in a research report on Friday. Jefferies Financial Group upped their target price on shares of Intuitive Surgical from $365.00 to $375.00 and gave the stock a “hold” rating in a research report on Friday. Mizuho upped their target price on shares of Intuitive Surgical from $350.00 to $390.00 and gave the stock a “neutral” rating in a research report on Thursday, January 25th. Finally, Truist Financial upped their target price on shares of Intuitive Surgical from $390.00 to $435.00 and gave the stock a “buy” rating in a research report on Wednesday, January 24th. Five equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $396.17.

Insider Buying and Selling

In related news, VP Marshall Mohr sold 108,790 shares of Intuitive Surgical stock in a transaction dated Wednesday, February 28th. The stock was sold at an average price of $385.08, for a total value of $41,892,853.20. Following the completion of the sale, the vice president now directly owns 26,877 shares in the company, valued at approximately $10,349,795.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other Intuitive Surgical news, VP Marshall Mohr sold 108,790 shares of the firm’s stock in a transaction dated Wednesday, February 28th. The stock was sold at an average price of $385.08, for a total value of $41,892,853.20. Following the transaction, the vice president now directly owns 26,877 shares of the company’s stock, valued at $10,349,795.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Myriam Curet sold 4,318 shares of the firm’s stock in a transaction dated Friday, January 26th. The stock was sold at an average price of $370.15, for a total value of $1,598,307.70. Following the completion of the transaction, the executive vice president now directly owns 189 shares in the company, valued at $69,958.35. The disclosure for this sale can be found here. In the last ninety days, insiders sold 248,418 shares of company stock worth $95,927,097. 0.90% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. Icon Wealth Advisors LLC purchased a new position in Intuitive Surgical in the fourth quarter worth about $135,000. Covestor Ltd boosted its position in Intuitive Surgical by 50.4% in the first quarter. Covestor Ltd now owns 418 shares of the medical equipment provider’s stock worth $126,000 after purchasing an additional 140 shares during the last quarter. Brown Brothers Harriman & Co. boosted its position in Intuitive Surgical by 576.7% in the first quarter. Brown Brothers Harriman & Co. now owns 406 shares of the medical equipment provider’s stock worth $122,000 after purchasing an additional 346 shares during the last quarter. LM Advisors LLC purchased a new position in shares of Intuitive Surgical during the 4th quarter valued at about $101,000. Finally, Chilton Capital Management LLC purchased a new position in shares of Intuitive Surgical during the 1st quarter valued at about $98,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.